2GX4 image
Entry Detail
PDB ID:
2GX4
Keywords:
Title:
Crystal structure of SARS coronavirus 3CL protease inhibitor complex
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2006-05-08
Release Date:
2007-05-08
Method Details:
Experimental Method:
Resolution:
1.93 Å
R-Value Free:
0.24
R-Value Work:
0.20
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:3C-like proteinase
Chain IDs:A
Chain Length:306
Number of Molecules:1
Biological Source:SARS coronavirus
Ligand Molecules
Primary Citation
Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor.
J.Med.Chem. 49 4971 4980 (2006)
PMID: 16884309 DOI: 10.1021/jm0603926

Abstact

A potent SARS coronavirus (CoV) 3CL protease inhibitor (TG-0205221, Ki = 53 nM) has been developed. TG-0205221 showed remarkable activity against SARS CoV and human coronavirus (HCoV) 229E replications by reducing the viral titer by 4.7 log (at 5 microM) for SARS CoV and 5.2 log (at 1.25 microM) for HCoV 229E. The crystal structure of TG-0205221 (resolution = 1.93 A) has revealed a unique binding mode comprising a covalent bond, hydrogen bonds, and numerous hydrophobic interactions. Structural comparisons between TG-0205221 and a natural peptide substrate were also discussed. This information may be applied toward the design of other 3CL protease inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures